Wellnex Life Limited
ASX: WNX
Brand-led growth lifts revenue and margins, with Pain Away and broader retail channels underpinning FY26 licensing-led expansion.
(Source: TradingView) 3-Month Performance Profile of WNX on a DTF compared to S&P/ASX 200 (XJO).
Wellnex Life Limited closed FY25 with revenue of $23.6 million, up 40.4% YoY, while gross profit rose 38.4% to $6.9 million. Despite ma
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Daily Digest
A$200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Daily Digest
Stay informed with expert daily ASX research covering four carefully selected stocks, complete with market insights, risk ratings, and clear Buy, Hold, or Sell general guidance—delivered before the market opens each trading day.
- ✓ Four Expert-Selected ASX Stocks Daily
- ✓ Weekday Pre-Market Delivery
- ✓ In-Depth Research & Analysis
- ✓ Access to All Previous Reports
A$200.00/ 12 months
Risk:Medium
Subscribe Now →
